Literature DB >> 22395895

Ischemic cardiac tissue conditioned media induced differentiation of human mesenchymal stem cells into early stage cardiomyocytes.

Balasundari Ramesh1, Dillip Kumar Bishi, Suneel Rallapalli, Sarasabarathi Arumugam, Kotturathu Mammen Cherian, Soma Guhathakurta.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent, can be easily expanded in culture and hence are an attractive therapeutic tool for cardiac repair. MSCs have tremendous potential to transdifferentiate to cardiac lineage both in vitro and in vivo. The present study examined the differentiation capacity of conditioned media derived from ischemic cardiac tissue on human MSCs. Human Bone marrow-derived MSCs after due characterization by immunocytochemistry and flow cytometry for MSC specific markers were induced by culture media derived from ischemic (n = 13) and non-ischemic (n = 18) human cardiac tissue. Parallel cultures were treated with 5-azacytidine (5-azaC), a potent cardiomyogen. MSCs induced with ischemic conditioned media formed myotube like structures, expressed sarcomeric Troponin I, alpha myosin heavy chain proteins and were positive for cardiac specific markers (Nkx2.5, human atrial natriuretic peptide, myosin light chain-2a, GATA-4) as was observed in 5-azaC treated cells. However, uninduced MSCs as well as those induced with non-ischemic cardiac conditioned media still maintained the fibroblast morphology even after 3 weeks post-induction. Transmission electron microscopic studies of cardiomyocyte-like cells derived from MSCs revealed presence of sarcomeric bands but failed to show gap junctions and intercalated discs as of adult cardiomyocytes. These findings demonstrate that ischemic cardiac conditioned media induces morphological and molecular changes in MSCs with cardiac features, but at a primitive stage. Proteomics analysis of the ischemic conditioned media revealed differential expression of three relevant proteins (C-type lectin superfamily member 13, Testis-specific chromodomain protein Y2 and ADP/ATP translocase 1), whose exact role in cardiac regeneration needs further analysis.

Entities:  

Year:  2012        PMID: 22395895      PMCID: PMC3432528          DOI: 10.1007/s10616-012-9440-7

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  25 in total

1.  Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes.

Authors:  K Fukuda
Journal:  Bone Marrow Transplant       Date:  2003-08       Impact factor: 5.483

2.  Stem cell transplantation for ischemic myocardium.

Authors:  Massimo A Mariani; Alessandro D'Alfonso; Mariagrazia Croccia; Ugo Limbruno; Rossella Di Stefano; Jan G Grandjean
Journal:  Ital Heart J       Date:  2004-05

Review 3.  Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro.

Authors:  Boon Chin Heng; Husnain Kh Haider; Eugene Kwang-Wei Sim; Tong Cao; Soon Chye Ng
Journal:  Cardiovasc Res       Date:  2004-04-01       Impact factor: 10.787

Review 4.  Stem cell therapy for myocardial repair.

Authors:  Peter L Weissberg; Asif Qasim
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

5.  The multiple ADP/ATP translocase genes are differentially expressed during human muscle development.

Authors:  J Lunardi; O Hurko; W K Engel; G Attardi
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

Review 6.  Transplantation of cells for cardiac repair.

Authors:  Rutger J Hassink; Aart Brutel de la Rivière; Christine L Mummery; Pieter A Doevendans
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

7.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

8.  Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation.

Authors:  Shu Xing Zhang; Eduardo Garcia-Gras; Diane R Wycuff; Suzanne J Marriot; Nijiati Kadeer; Wei Yu; Eric N Olson; Daniel J Garry; Michael S Parmacek; Robert J Schwartz
Journal:  J Biol Chem       Date:  2005-01-28       Impact factor: 5.157

Review 9.  Cardiac remodeling in coronary artery disease.

Authors:  Norman Sharpe
Journal:  Am J Cardiol       Date:  2004-05-06       Impact factor: 2.778

10.  Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.

Authors:  R Jüttermann; E Li; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

View more
  4 in total

Review 1.  Innate immunity and cardiomyocytes in ischemic heart disease.

Authors:  Li Lin; Anne A Knowlton
Journal:  Life Sci       Date:  2014-01-28       Impact factor: 5.037

2.  Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle.

Authors:  Timur Fatkhudinov; Galina Bolshakova; Irina Arutyunyan; Andrey Elchaninov; Andrey Makarov; Evgeniya Kananykhina; Oksana Khokhlova; Arkady Murashev; Valeria Glinkina; Dmitry Goldshtein; Gennady Sukhikh
Journal:  Stem Cells Int       Date:  2015-01-21       Impact factor: 5.443

Review 3.  Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).

Authors:  Aastha Singh; Abhishek Singh; Dwaipayan Sen
Journal:  Stem Cell Res Ther       Date:  2016-06-04       Impact factor: 6.832

4.  Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Improves Energetic Status and Cardiomyogenic Differentiation of Human Dilated Myocardium-Derived Primary Mesenchymal Cells.

Authors:  Rokas Miksiunas; Kestutis Rucinskas; Vilius Janusauskas; Siegfried Labeit; Daiva Bironaite
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.